Loading institutional data...
Loading institutional data...
Insufficient data to determine institutional momentum.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
No trend data available for this metric.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $19.6M 100.0% | $29.6M 100.0% | $18.1M 100.0% | $25.4M 100.0% | — |
| Cost of Revenue | $10.7M 54.6% | $16.3M 55.1% | $10.2M 56.4% | $14.5M 57.3% | — |
| Gross Profit | $8.9M 45.4% | $13.3M 44.9% | $7.9M 43.6% | $10.8M 42.7% | — |
| Research & Development | — | — | $15.1M 83.6% | $16.5M 65.0% | — |
| Selling, General & Admin | $17.5M 89.2% | $19.9M 67.1% | $20.9M 115.6% | $13.5M 53.2% | $3.4M |
| Total Operating Expenses | $17.5M 89.2% | $19.9M 67.1% | — | $736K 2.9% | — |
| Operating Income | -$8.6M -43.8% | -$6.6M -22.3% | -$13.0M -71.9% | -$2.6M -10.4% | -$3.4M |
| Interest Expense | $886K 4.5% | -$14K -0.0% | — | — | — |
| Interest & Investment Income | — | $14K 0.0% | $172K 1.0% | $3.2M 12.4% | $27K |
| Other Income (Expense), net | $1.0M 5.3% | -$8.5M -28.6% | -$7.9M -43.5% | -$159K -0.6% | — |
| Pretax Income | -$7.6M -38.5% | -$15.0M -50.9% | -$20.8M -115.4% | -$2.8M -11.1% | -$2.1M |
| Income Tax Expense | $11K 0.1% | $114K 0.4% | $11K 0.1% | $106K 0.4% | $0 |
| Net Income | -$7.6M -38.5% | -$15.2M -51.2% | -$20.9M -115.5% | -$2.9M -11.5% | -$2.1M |
| Per Share | |||||
| EPS (Basic) | $-0.29 | $-0.85 | $-1.48 | $-0.22 | — |
| EPS (Diluted) | $-0.29 | $-0.85 | $-1.48 | $-0.22 | — |
| Weighted Avg Shares (Basic) | 26.5M | 17.9M | 14.1M | 13.1M | — |
| Weighted Avg Shares (Diluted) | 26.5M | 17.9M | 14.1M | 13.1M | — |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81 · book equity (no price)
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage falling year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 5 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Insufficient data. Current ROIC on all capital: 4006%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 5 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $15M covers all $9M of scheduled principal — no refinancing pressure. Scheduled principal only (excludes interest & revolver draws). As of 2025-12-31 (10-K).
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~16.0% on $6M of debt.
Cash vs short-term debt unavailable.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
No current price collected.
Where each multiple sits in its own 5-yr range
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 5-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Returns are margin-driven, not leverage-driven — higher quality.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cost of Revenue | — | 57.3 | 56.4 | 55.1 | 54.6 |
| Gross Profit | — | 42.7 | 43.6 | 44.9 | 45.4 |
| R&D | — | 65.0 | 83.6 | — | — |
| SG&A | — | 53.2 | 115.6 | 67.1 | 89.2 |
| Operating Income | — | -10.4 | -71.9 | -22.3 | -43.8 |
| Income Tax | — | 0.4 | 0.1 | 0.4 | 0.1 |
| Net Income | — | -11.5 | -115.5 | -51.2 | -38.5 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on MDAI: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Top 24 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position